Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Times Interest Earned (2021 - 2026)

bioAffinity Technologies has reported Times Interest Earned over the past 5 years, most recently at -$404.67 for Q1 2026.

  • Quarterly Times Interest Earned fell 138.52% to -$404.67 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$11.96 through Mar 2026, up 93.49% year-over-year, with the annual reading at -$21.04 for FY2025, 97.6% up from the prior year.
  • Times Interest Earned was -$404.67 for Q1 2026 at bioAffinity Technologies, down from -$6.66 in the prior quarter.
  • Over five years, Times Interest Earned peaked at -$1.09 in Q3 2022 and troughed at -$368319.1 in Q4 2024.
  • The 5-year median for Times Interest Earned is -$148.6 (2024), against an average of -$23275.8.
  • Year-over-year, Times Interest Earned tumbled 220365.82% in 2024 and then skyrocketed 100.0% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at -$18.19 in 2022, then plummeted by 818.69% to -$167.06 in 2023, then plummeted by 220365.82% to -$368319.1 in 2024, then skyrocketed by 100.0% to -$6.66 in 2025, then plummeted by 5977.61% to -$404.67 in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Times Interest Earned are -$404.67 (Q1 2026), -$6.66 (Q4 2025), and -$597.25 (Q3 2025).